BAY3427080 (NT-814)

NT-814 · Bayer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BAY3427080 (NT-814), covering 2021-02-16 to 2023-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms [Phase 2]

See pricing